IL37640A - Veterinary pharmaceutical mixtures containing a result of the amino carboxylic acid - Google Patents

Veterinary pharmaceutical mixtures containing a result of the amino carboxylic acid

Info

Publication number
IL37640A
IL37640A IL37640A IL3764071A IL37640A IL 37640 A IL37640 A IL 37640A IL 37640 A IL37640 A IL 37640A IL 3764071 A IL3764071 A IL 3764071A IL 37640 A IL37640 A IL 37640A
Authority
IL
Israel
Prior art keywords
salt
thyroxine
thyronine
triiodo
component
Prior art date
Application number
IL37640A
Other languages
English (en)
Hebrew (he)
Other versions
IL37640A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL37640A0 publication Critical patent/IL37640A0/xx
Publication of IL37640A publication Critical patent/IL37640A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL37640A 1971-05-28 1971-09-02 Veterinary pharmaceutical mixtures containing a result of the amino carboxylic acid IL37640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712126533 DE2126533A1 (de) 1971-05-28 1971-05-28 Verfahren zur Herstellung pharma zeutischer Zubereitungen

Publications (2)

Publication Number Publication Date
IL37640A0 IL37640A0 (en) 1971-12-29
IL37640A true IL37640A (en) 1974-10-22

Family

ID=5809169

Family Applications (1)

Application Number Title Priority Date Filing Date
IL37640A IL37640A (en) 1971-05-28 1971-09-02 Veterinary pharmaceutical mixtures containing a result of the amino carboxylic acid

Country Status (13)

Country Link
US (1) US3917832A (de)
AT (1) AT306228B (de)
AU (1) AU3450471A (de)
BE (1) BE773121A (de)
BR (1) BR7105898D0 (de)
DE (1) DE2126533A1 (de)
ES (1) ES394319A1 (de)
FR (1) FR2139787B1 (de)
GB (1) GB1296510A (de)
HU (1) HU162454B (de)
IL (1) IL37640A (de)
NL (1) NL7111198A (de)
ZA (1) ZA715734B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401891D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE19821625C1 (de) 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
WO2004041208A2 (en) * 2002-11-05 2004-05-21 New River Pharmaceuticals Inc. Controlled absorption of mixed thyroyd hormone formulations
AU2008240374A1 (en) * 2007-04-23 2008-10-30 Diurnal Limited Sustained release
CA2761298A1 (en) * 2009-05-15 2010-11-18 The University Of Kentucky Research Foundation Treatment of mci and alzheimer's disease
US9968574B2 (en) * 2009-05-15 2018-05-15 The University Of Kentucky Research Foundation Treatment of MCI and Alzheimer's disease
JP2013526518A (ja) * 2010-05-13 2013-06-24 ザ ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション Ｍｃｉおよびアルツハイマー病の処置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2925364A (en) * 1957-08-12 1960-02-16 Baxter Laboratories Inc Method of treating hypercholesterol-emia with d-thyroxine
US3157574A (en) * 1959-05-01 1964-11-17 Smith Kline French Lab Method of reducing cholesterol levels

Also Published As

Publication number Publication date
FR2139787A1 (de) 1973-01-12
BR7105898D0 (pt) 1973-05-10
HU162454B (de) 1973-02-28
ES394319A1 (es) 1975-04-01
US3917832A (en) 1975-11-04
IL37640A0 (en) 1971-12-29
AU3450471A (en) 1973-04-19
FR2139787B1 (de) 1974-09-06
ZA715734B (en) 1973-04-25
AT306228B (de) 1973-03-26
BE773121A (fr) 1972-03-27
GB1296510A (de) 1972-11-15
DE2126533A1 (de) 1972-12-14
NL7111198A (de) 1972-11-30

Similar Documents

Publication Publication Date Title
US4415554A (en) Treatment for menstrual disorders
US4309415A (en) Method and composition for treating inflammatory disorders
US5324522A (en) Sustained release thyroactive composition
US6051587A (en) Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US4415576A (en) Method for preventing body fat deposition in mammals
ZA200106029B (en) Essential fatty acids in the prevention of cardiovascular events.
JPWO2004019928A1 (ja) 肝疾患治療剤
US4387093A (en) Arthritis treatment
US4021555A (en) Pharmaceutical preparation and method for treatment of parkinsonism
US3917832A (en) Compositions comprising d-thyroxine and d-triiodothyronine
US2789938A (en) Method of producing a diuretic effect with p-carboxybenzenesulfonamide
KR100907938B1 (ko) 발기 기능장애의 치료를 위한 알카노일 ｌ-카르니틴의 용도
AU2022212793A1 (en) Use of exogenous ketone esters to induce weight loss in mammals
US20110117070A1 (en) Compositions and methods for treating headache
JPH0140009B2 (de)
AU2019315823A1 (en) New use of carbamate beta phenylethanolamine analogues for enhancing intracellular clearance of ldl cholesterol and for combining therapy with statins to enhance the efficacy and reduce adverse effects
IL29581A (en) Pharmaceutical preparations containing a hydroxycoumarin compound having both hypotensive and spasmolytic action
US4042698A (en) Treatment of myasthenia gravis and oral medication therefor
US2403473A (en) Therapeutic compositions
US3932652A (en) Antidepressant compositions
WO2009108297A2 (en) Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
US4575506A (en) Method of treatment for inhibiting the tolerance onset while treating painful syndromes with central analgesics
JPS5938204B2 (ja) 再生不良性貧血治療剤
US3963834A (en) Pharmaceutical compositions for the treatment of hydropic conditions
KR20020025066A (ko) ＨＭＧ-ＣｏＡ 리덕타제 억제제 및 카르니틴을 포함하는항지질혈성 복합제